{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:19:41Z","timestamp":1782112781541,"version":"3.54.5"},"reference-count":147,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.survophthal.2023.01.007","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T02:37:18Z","timestamp":1675132638000},"page":"332-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of systemic drugs on the development and progression of age-related macular degeneration"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4160-7020","authenticated-orcid":false,"given":"Kara R.","family":"Grimes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilasha","family":"Aloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Skondra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-9680","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2023.01.007_bib0001","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/466S6a","article-title":"Levodopa: the story so far","volume":"466","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0002","doi-asserted-by":"crossref","first-page":"657","DOI":"10.18502\/jovr.v16i4.9756","article-title":"Intravitreal Methotrexate","volume":"16","author":"Abdi","year":"2021","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0003","first-page":"2224","article-title":"Age-Related Eye Disease Study Research Group, Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-related eye disease study report number 3","volume":"107","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0004","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2147\/CIA.S143508","article-title":"Recent developments in age-related macular degeneration: a review","volume":"12","author":"Al-Zamil","year":"2017","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000333824","article-title":"Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?","volume":"227","author":"Aliferis","year":"2012","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0006","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.atherosclerosis.2006.08.041","article-title":"Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries","volume":"193","author":"Alvarez de Sotomayor","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0007","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4161\/cc.9.1.10407","article-title":"Metformin extends life span of HER-2\/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo","volume":"9","author":"Anisimov","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0008","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0009","first-page":"59","article-title":"L-dopa therapy in Parkinson's disease: a critical review of nine years' experience","volume":"101","author":"Barbeau","year":"1969","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/vhrm.2006.2.4.411","article-title":"Sildenafil in the treatment of pulmonary hypertension","volume":"2","author":"Barnett","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0011","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0012","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.37765\/ajmc.2020.43435","article-title":"Wet age-related macular degeneration: treatment advances to reduce the injection burden","volume":"26","author":"Baumal","year":"2020","journal-title":"Am J Manag Care"},{"issue":"Pt 2","key":"10.1016\/j.survophthal.2023.01.007_bib0013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/eye.1990.43","article-title":"Control of retinal and choroidal blood flow","volume":"4","author":"Bill","year":"1990","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0014","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jamaophthalmol.2020.6331","article-title":"Association of metformin use with age-related macular degeneration: a case-control study","volume":"139","author":"Blitzer","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/jamaophthalmol.2021.2132","article-title":"Methodological considerations for the case-control study of metformin and age-related macular degeneration-reply","volume":"139","author":"Blitzer","year":"2021","journal-title":"JAMA Ophthalmol,"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0016","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjmed.2015.10.015","article-title":"Mining retrospective data for virtual prospective drug repurposing: L-DOPA and age-related macular degeneration","volume":"129","author":"Brilliant","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/NDT.S1660","article-title":"Optimizing levodopa therapy for Parkinson's disease with levodopa\/carbidopa\/entacapone: implications from a clinical and patient perspective","volume":"4","author":"Brooks","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0018","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0019","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1167\/iovs.18-26422","article-title":"The common antidiabetic drug metformin reduces odds of developing age-related macular degeneration","volume":"60","author":"Brown","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.02.035","article-title":"Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism","volume":"153","author":"Cabreiro","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0021","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2007.06.018","article-title":"Anterior ischemic optic neuropathy and stroke with use of PDE-5 inhibitors for erectile dysfunction: cause or coincidence?","volume":"262","author":"Carter","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0022","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.2146\/ajhp050519","article-title":"Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs","volume":"63","author":"Chaiamnuay","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.580884","article-title":"Fenofibrate inhibits subretinal fibrosis through suppressing TGF-beta-Smad2\/3 signaling and Wnt signaling in neovascular age-related macular degeneration","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/db11-0413","article-title":"Therapeutic effects of PPARalpha agonists on diabetic retinopathy in type 1 diabetes models","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1649156","article-title":"Association between metformin and a lower risk of age-related macular degeneration in patients with type 2 diabetes","volume":"2019","author":"Chen","year":"2019","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0026","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.2014.889680","article-title":"Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?","volume":"13","author":"Christen","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0027","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.ophtha.2009.05.031","article-title":"Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women","volume":"116","author":"Christen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/01.WNO.0000166061.73483.CE","article-title":"Reversible optic neuropathy associated with low-dose methotrexate therapy","volume":"25","author":"Clare","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0029","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3899\/jrheum.200124","article-title":"Methotrexate in psoriasis and psoriatic arthritis","volume":"96","author":"Coates","year":"2020","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000486105","article-title":"Treatment of macular degeneration with sildenafil: results of a two-year trial","volume":"240","author":"Coleman","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0031","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/bjophthalmol-2013-303143","article-title":"Age-related macular degeneration: choroidal ischaemia?","volume":"97","author":"Coleman","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0032","series-title":"Metformin","author":"Corcoran","year":"2021"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0033","first-page":"515","article-title":"[Therapeutic and pharmacologic perspectives in Parkinson's disease]","volume":"68","author":"Corvol","year":"2018","journal-title":"Rev Prat"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0034","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00041327-200103000-00006","article-title":"Anterior ischemic optic neuropathy associated with viagra","volume":"21","author":"Cunningham","year":"2001","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0036","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/ard.60.8.729","article-title":"Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis","volume":"60","author":"Cutolo","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0037","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1111\/j.1755-3768.2011.02117.x","article-title":"Beta blocker use and age-related macular degeneration","volume":"90","author":"Davis","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0038","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archopht.122.4.575","article-title":"Extremely discordant sib-pair study design to determine risk factors for neovascular age-related macular degeneration","volume":"122","author":"DeAngelis","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0039","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2008.02.006","article-title":"The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients","volume":"81","author":"Ersoy","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/hmg\/ddv477","article-title":"Preferential PPAR-alpha activation reduces neuroinflammation, and blocks neurodegeneration in vivo","volume":"25","author":"Esmaeili","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0041","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaophthalmol.2021.2129","article-title":"Methodological considerations for the case-control study of metformin and age-related macular degeneration","volume":"139","author":"Etminan","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0042","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjmed.2020.05.038","article-title":"Levodopa positively affects neovascular age-related macular degeneration","volume":"134","author":"Figueroa","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0043","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9394(01)00872-8","article-title":"Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration","volume":"132","author":"Flower","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0044","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0045","first-page":"129","article-title":"Choroidal microcirculation in vivo","volume":"7","author":"Friedman","year":"1965","journal-title":"Bibl Anat"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0046","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0047","series-title":"Levodopa (L-Dopa)","author":"Gandhi","year":"2021"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0048","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5005\/jp-journals-10008-1155","article-title":"Effect of topical calcium channel blockers on intraocular pressure in steroid-induced glaucoma","volume":"8","author":"Ganekal","year":"2014","journal-title":"J Curr Glaucoma Pract"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0049","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006927.pub5","article-title":"Statins for age-related macular degeneration","author":"Gehlbach","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0051","series-title":"Nonsteroidal Anti-inflammatory Drugs (NSAIDs)","author":"Ghlichloo","year":"2021"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0052","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1097\/IAE.0b013e31825be87f","article-title":"Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration","volume":"32","author":"Gomi","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0053","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Group","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0054","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0002-9394(02)01391-0","article-title":"Effect of sildenafil citrate (Viagra) on retinal blood vessel diameter","volume":"133","author":"Grunwald","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0055","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0002-9394(00)00944-2","article-title":"Effect of sildenafil citrate (Viagra) on the ocular circulation","volume":"131","author":"Grunwald","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0056","series-title":"Methotrexate","author":"Hannoodee","year":"2021"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0057","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1468-3083.2000.00058.x","article-title":"Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment","volume":"14","author":"Haustein","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0058","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/bega.2001.0236","article-title":"COX-1 and COX-2 inhibitors","volume":"15","author":"Hawkey","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0059","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0161-6420(96)30593-9","article-title":"Risk factors of age-related maculopathy in a population 70 years of age or older","volume":"103","author":"Hirvela","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0060","first-page":"S172","article-title":"Review of neovascular age-related macular degeneration treatment options","volume":"25","author":"Holekamp","year":"2019","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0061","first-page":"1328","article-title":"Therapeutic effects of fenofibrate nano-emulsion eye drops on retinal vascular leakage and neovascularization","volume":"10","author":"Huang","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0062","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.118.3.351","article-title":"Hypertension, cardiovascular disease, and age-related macular degeneration. age-related macular degeneration risk factors study group","volume":"118","author":"Hyman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0063","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1056\/NEJMra0801537","article-title":"Age-related macular degeneration","volume":"358","author":"Jager","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0064","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","article-title":"Topical application of methotrexate for inhibition of corneal angiogenesis","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1076\/ocii.11.2.131.15919","article-title":"Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis","volume":"11","author":"Kaplan-Messas","year":"2003","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0066","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0067","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1755-3768.2011.02305.x","article-title":"Measurement of choroidal perfusion and thickness following systemic sildenafil (Viagra(R))","volume":"91","author":"Kim","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0068","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archophthalmol.2010.92","article-title":"The prevalence of age-related macular degeneration and associated risk factors","volume":"128","author":"Klein","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0069","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archopht.119.9.1354","article-title":"Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study","volume":"119","author":"Klein","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2006.10.040","article-title":"Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study","volume":"114","author":"Klein","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0071","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ophtha.2014.03.005","article-title":"Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study","volume":"121","author":"Klein","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0072","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0420.2005.00422.x","article-title":"The effects of sildenafil on ocular blood flow","volume":"83","author":"Koksal","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0073","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/IAE.0000000000002059","article-title":"Systemic beta-blockers and risk of progression to neovascular age-related macular degeneration","volume":"39","author":"Kolomeyer","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0074","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/786870","article-title":"Anti-VEGF treatment strategies for wet AMD","volume":"2012","author":"Kovach","year":"2012","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0075","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/j.1755-3768.2009.01560.x","article-title":"Intravitreal methotrexate in therapeutically resistant exudative age-related macular degeneration","volume":"88","author":"Kurup","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0076","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"Labuzek","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0077","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Leaute-Labreze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0078","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/j.1755-3768.2008.01491.x","article-title":"Topical nepafenac for treatment of exudative age-related macular degeneration","volume":"88","author":"Libondi","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0079","first-page":"472","article-title":"[Anatomy histology and physiology of capillary vessels of the eye fundus]","volume":"9","author":"Lieb","year":"1967","journal-title":"Med Welt"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0080","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1371\/journal.pbio.0060236","article-title":"L-DOPA is an endogenous ligand for OA1","volume":"6","author":"Lopez","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0081","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12974-015-0295-7","article-title":"The role of PPAR activation during the systemic response to brain injury","volume":"12","author":"Losey","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0082","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/aos.15056","article-title":"Associations between systemic medications and development of wet age-related macular degeneration","volume":"100","author":"Loukovaara","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0083","first-page":"347","article-title":"Therapeutic potential of topical fenofibrate eyedrops in diabetic retinopathy and AMD rat models","volume":"5","author":"Lu","year":"2014","journal-title":"J Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0084","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1097-0142(197701)39:1<58::AID-CNCR2820390111>3.0.CO;2-5","article-title":"Blindness during remission in two patients with acute lymphoblastic leukemia: a possible complication of multimodality therapy","volume":"39","author":"Margileth","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0039-6257(99)00079-X","article-title":"Sildenafil (Viagra) and ophthalmology","volume":"44","author":"Marmor","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0086","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0087","article-title":"Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans","author":"Mauschitz","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0088","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000067549","article-title":"Effects of sildenafil citrate (Viagra) on choroidal congestion","volume":"216","author":"McCulley","year":"2002","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0089","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.2005.083519","article-title":"Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction","volume":"90","author":"McGwin","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0090","series-title":"Calcium Channel Blockers","author":"McKeever","year":"2022"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0091","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-beta: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0092","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2005.01.017","article-title":"Effect of Viagra on the foveolar choroidal circulation of AMD patients","volume":"81","author":"Metelitsina","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0093","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.exer.2005.11.012","article-title":"Effect of viagra on retinal vein diameter in AMD patients","volume":"83","author":"Metelitsina","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0094","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajo.2018.01.012","article-title":"The relationship between nonsteroidal anti-inflammatory drug use and age-related macular degeneration","volume":"188","author":"Modjtahedi","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0096","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/IAE.0b013e3182695ba0","article-title":"Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab","volume":"33","author":"Montero","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0097","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000331111","article-title":"Bilateral simultaneous anterior ischemic optic neuropathy associated with sildenafil","volume":"2","author":"Moschos","year":"2011","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0098","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archopht.118.6.819","article-title":"Causes of blindness and visual impairment in a population of older Americans: the salisbury eye evaluation study","volume":"118","author":"Munoz","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0099","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.27172","article-title":"Levodopa treatment and dendritic spine pathology","volume":"33","author":"Nishijima","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jama.2008.694","article-title":"Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial","volume":"300","author":"Nurnberg","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0101","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1167\/iovs.05-1370","article-title":"The beta-adrenergic receptor antagonist metipranolol blunts zinc-induced photoreceptor and RPE apoptosis","volume":"47","author":"Osborne","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/aian.AIAN_241_17","article-title":"Levodopa: history and therapeutic applications","volume":"20","author":"Ovallath","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0103","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/TA.0000000000000755","article-title":"Nonopioid management of acute pain associated with trauma: Focus on pharmacologic options","volume":"79","author":"Oyler","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1023\/A:1014410932321","article-title":"Sildenafil increases ocular perfusion","volume":"23","author":"Paris","year":"2001","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0105","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2016.0606","article-title":"Warfarin use among wet AMD patients","volume":"94","author":"Paterno","year":"2016","journal-title":"Acta Ophthalmologica"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0106","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203309360539","article-title":"Ocular side effects of anti-rheumatic medications: what a rheumatologist should know","volume":"19","author":"Peponis","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0107","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1167\/iovs.03-0177","article-title":"Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects","volume":"44","author":"Polak","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0108","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0161-6420(01)00976-9","article-title":"Sildenafil-associated nonarteritic anterior ischemic optic neuropathy","volume":"109","author":"Pomeranz","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0109","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","article-title":"Fenofibrate-loaded biodegradable nanoparticles for the treatment of experimental diabetic retinopathy and neovascular age-related macular degeneration","volume":"16","author":"Qiu","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","article-title":"Parkinson's disease","volume":"103","author":"Reich","year":"2019","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0111","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0112","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0113","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ophtha.2018.09.014","article-title":"Long-term regular use of low-dose aspirin and neovascular age-related macular degeneration: national sample cohort 2010-2015","volume":"126","author":"Rim","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0114","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mdc3.12688","article-title":"Levodopa-induced neuropathy: a systematic review","volume":"6","author":"Romagnolo","year":"2019","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1387\/ijdb.041895ms","article-title":"Development and pathology of the hyaloid, choroidal and retinal vasculature","volume":"48","author":"Saint-Geniez","year":"2004","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0116","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1871530315666150316124019","article-title":"Metformin and inflammation: its potential beyond glucose-lowering effect","volume":"15","author":"Saisho","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0117","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0118","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nn.3772","article-title":"LKB1 and AMPK regulate synaptic remodeling in old age","volume":"17","author":"Samuel","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0119","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-4835(02)00247-6","article-title":"Loss of melanin from human RPE with aging: possible role of melanin photooxidation","volume":"76","author":"Sarna","year":"2003","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0120","article-title":"Systemic nsaids and age-related macular degeneration: The Age-Related Eye Disease Study (AREDS)","volume":"48","author":"Sen","year":"2007","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0121","series-title":"Fenofibrate","author":"Sidhu","year":"2021"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.EEM.0000292055.24233.39","article-title":"Sildenafil effectively treats raynaud's phenomenon","volume":"28","year":"2006","journal-title":"Emerg Med News"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0123","series-title":"Sildenafil","author":"Smith","year":"2021"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0124","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ajo.2013.04.023","article-title":"Regular aspirin use and risk of age-related macular degeneration","volume":"156","author":"Sobrin","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5301\/EJO.2010.5696","article-title":"Pilot study of safety and effect of combined intravitreal bevacizumab and methotrexate for neovascular age-related macular degeneration","volume":"21","author":"Soheilian","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0126","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/IAE.0000000000003075","article-title":"Systemic medication use and the incidence and growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials","volume":"41","author":"Song","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0127","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fneur.2020.00556","article-title":"Metformin as a potential neuroprotective agent in prodromal parkinson's disease-viewpoint","volume":"11","author":"Sportelli","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0128","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.oret.2020.06.003","article-title":"Relationship between oral metformin use and age-related macular degeneration","volume":"4","author":"Stewart","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/eye.2016.265","article-title":"Risk of intraocular hemorrhage with new oral anticoagulants","volume":"31","author":"Talany","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0130","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","article-title":"Levodopa in Parkinson's disease: current status and future developments","volume":"16","author":"Tambasco","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0131","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.7150\/ijbs.49890","article-title":"The role of inflammation in age-related macular degeneration","volume":"16","author":"Tan","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0132","first-page":"2149","article-title":"Intraocular methotrexate can induce extended remission in some patients in noninfectious events","volume":"33","author":"Taylor","year":"2013","journal-title":"J Retina Vit Dis"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0133","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/ijir.2008.25","article-title":"Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction","volume":"20","author":"Thurtell","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0134","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/PL00007887","article-title":"Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration","volume":"238","author":"Tilanus","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/IAE.0000000000001226","article-title":"Systemic beta-blockers in neovascular age-related macular degeneration","volume":"37","author":"Traband","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0136","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ophtha.2003.10.024","article-title":"Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents","volume":"111","author":"van Leeuwen","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0137","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/IAE.0b013e3181eef0ae","article-title":"The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography","volume":"31","author":"Vance","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0138","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamaophthalmol.2022.1435","article-title":"Association of diabetes medication with open-angle glaucoma, age-related macular degeneration, and cataract in the rotterdam study","volume":"140","author":"Vergroesen","year":"2022","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0139","first-page":"13","article-title":"Effect of sildenafil citrate on choroidal thickness in age-related macular degeneration","volume":"58","author":"Vuong","year":"2017","journal-title":"Investigat Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0140","first-page":"493","article-title":"[Mode of action of sildenafil]","volume":"21","author":"Wang","year":"1999","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0141","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/eye.2010.196","article-title":"The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment","volume":"25","author":"Wang","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0142","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0143","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1038\/eye.2012.201","article-title":"Enhanced depth imaging spectral-domain optical coherence tomography of a subtle choroidal metastasis","volume":"26","author":"Witkin","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0144","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1073\/pnas.1802724115","article-title":"Stimulation of AMPK prevents degeneration of photoreceptors and the retinal pigment epithelium","volume":"115","author":"Xu","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.survophthal.2023.01.007_bib0145","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/ICB.0000000000000708","article-title":"Sildenafil citrate induced retinal toxicity-electroretinogram, optical coherence tomography, and adaptive optics findings","volume":"12","author":"Yanoga","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0146","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41598-019-41509-2","article-title":"Vascular response to sildenafil citrate in aging and age-related macular degeneration","volume":"9","author":"Yiu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.01.007_bib0147","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/IAE.0b013e3181b32f4c","article-title":"Retrospective review of the efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration","volume":"29","author":"Zweifel","year":"2009","journal-title":"Retina"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:53:30Z","timestamp":1758542010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625723000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":147,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0039625723000097"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.01.007","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of systemic drugs on the development and progression of age-related macular degeneration","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}